knowledge -WSS

knowledge

author：hotspot 2025-09-28 02:31:38 - browse：9

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval but leaving physicians with lingering questions about the medicine’s impact on patients as a new era in Alzheimer’s therapy unfolds.

The drug, called donanemab, showed a 35% slowing of Alzheimer’s disease progression relative to placebo in a clinical trial that enrolled 1,700 patients with early-stage disease. Numerically, that’s a modest, 3.3-point improvement on a 144-point survey, called the Integrated Alzheimer’s Disease Rating Scale, or iADRS, that combines measures of cognition and function, such as driving, managing finances, or carrying on conversations.

There was a similar benefit when donanemab’s efficacy was assessed using a more common measure of cognition called the Clinical Dementia Rating-Sum of Boxes, or CDR-SB. On that scale, the Lilly drug showed a 36% slowing of cognitive decline relative to placebo, or 0.68 points on an 18-point scale.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Restaurant meals are packed with calories, and we still keep eating them

WSS

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

With heat waves through August, officials warn of health risks

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Rare Northern Lights show in US this week: Where and how to see it

US intelligence assessment says Iran not currently developing nuclear weapons

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Wikipedia

knowledge

knowledge

Medicare details structure of new drug price negotiation program

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Tori Bowie and the unacceptable rates of Black maternal death

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Another man arrested in connection with shooting at Kansas nightclub

Heart attack and stroke risk calculators need revising

Tuberculosis patients need more than just free medication

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Election results set back Medicaid expansion plans

knowledge

How redistricting in 6 states could affect who controls Congress

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

How redistricting in 6 states could affect who controls Congress

Failure, not just success, should guide future doctors

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

explore

leisure time

hotspot

focus